66th Day Of Lockdown

Maharashtra59546186161982 Tamil Nadu1937210548148 Delhi162817495316 Gujarat155728003960 Rajasthan80674815180 Madhya Pradesh74534050321 Uttar Pradesh71704215197 West Bengal45361668295 Andhra Pradesh3245213359 Bihar3185105015 Karnataka253381847 Telangana2256134567 Punjab2158194640 Jammu and Kashmir203685927 Odisha16608877 Haryana150488119 Kerala10895558 Assam8801044 Uttarakhand493794 Jharkhand4621914 Chandigarh3641894 Chhatisgarh364830 Tripura2421650 Himachal Pradesh223634 Goa68370 Puducherry49170 Meghalaya20121 Nagaland1800 Manipur540 Arunachal Pradesh210 Mizoram110 Sikkim100
Lifestyle Health and Wellbeing 19 Apr 2018 New target found for ...

New target found for breast cancer therapies

ANI
Published Apr 19, 2018, 9:39 am IST
Updated Apr 19, 2018, 9:39 am IST
According to study, the protein is strongly associated with metastatic breast cancer and that could be a target for future therapies.
Metastatic breast cancer is cancer that has spread to other sites in the body, and the vast majority of breast cancer deaths occur in patients in whom cancer has metastasised. (Photo: Pixabay)
 Metastatic breast cancer is cancer that has spread to other sites in the body, and the vast majority of breast cancer deaths occur in patients in whom cancer has metastasised. (Photo: Pixabay)

Washington DC: A new protein has been found that is associated with breast cancer patients' survival.

According to a study conducted by the UT Southwestern Medical Center, this protein is strongly associated with metastatic breast cancer and that could be a target for future therapies.

 

High levels of the protein ZMYND8 are correlated with poor survival in breast cancer patients, said researcher Weibo Luo.

Previous research has shown that breast cancer cells are more aggressive in an oxygen-deprived, or hypoxic, environment. A protein family called hypoxia-inducible factor (HIF) controls responses to hypoxia, switching on pathways that lead to cancer cell growth and spread.

"Our research shows that ZMYND8 is a regulator that activates hundreds of HIF-dependent oncogenes in breast cancer cells," Luo said.

"Our studies uncovered a feedback loop that amplifies HIF-controlled oncogenes to drive breast tumor malignancy," said researcher Yingfei Wang.

Approximately 250,000 women were diagnosed with breast cancer in 2017, according to National Institutes of Health figures, and about 40,000 died of the disease.

Metastatic breast cancer is cancer that has spread to other sites in the body, and the vast majority of breast cancer deaths occur in patients in whom cancer has metastasised.

"This work uncovers a primary epigenetic mechanism of HIF-mediated breast cancer progression, and reveals a possible molecular target for diagnosis and treatment of aggressive disease," Luo said.

The research appears in the Journal of Clinical Investigation.

...




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT